Below, find summaries of May’s four passed proposals. More in-depth descriptions can be found on Snapshot
! As always, you can follow proposals and add to the conversation before votes are added to Snapshot on the VitaDAO’s Discourse.
There are currently multiple proposals being discussed on Discourse, including VDP-46 (Repair Biotechnologies), VDP-44 (Dispute Resolution Process), VDP-45 (Decentralized Tech Transfer), VDP-29 (Exosomes for treating systemic inflammation), VDP-36 (Stewardship Process Amendment #1), VDP-37 (VitaDAO Governance Amendment #2), and VDP-26.1 (Dealflow structure & incentives).
VDP-43 initiates a partnership with BanklessDAO. As a result of this proposal, VitaDAO and BanklessDAO will token swap $25,000 worth of $VITA for $25,000 of $BANK taken at the 30-day moving average. VitaDAO is excited about this partnership as it means further treasury diversification and increased DAO awareness! 🤝
This proposal allocates $231,000 to Dr. Tim Peterson’s project to develop a cellular soap to simultaneously block both pathogens and senescent cells. It has been appreciated that pathogens age humans by driving cell senescence. This research project offers a promising strategy to thwart pathogens and different aging pathologies.
VDP-42 confirms an additional $580,000 arm’s-length loan from VitaDAO to VHF, secured against the underlying equity in companies VHF in turn funds, and a $100,000 donation to VHF to support VHF and VitaDAO’s aligned non-profit initiatives. VitaDAO, through the secured loan agreement for $580,000, will help VHF fund 10 projects within the $50-100K range.
VDP-22 provides 50,000 USD of funding to a 4-year doctoral research program at the Institute of Chemical Biology, Imperial College London. The program plans on probing DNA quadruplexes in age-related proteostasis. In exchange for supporting this doctoral program, VitaDAO expects to have access to IP licensing rights (potentially related to therapeutic compounds or biologics) derived from the research program via an IP-NFT via Molecule.